As part of its inaugural PDA Biopharmaceuticals Week, PDA will host the 2019 PDA Cell and Gene Therapy Conference. Building on the success of PDA’s recent Cell and Gene Therapy Conference in October 2018, this event will explore the most recent advances in this rapidly evolving area.

Don’t miss the mix of plenary sessions, a topic-specific Interest Group breakfast session, and exciting question and answer opportunities with the foremost industry experts in the field of cell and gene therapy. The lineup of noted speakers will present on key issues facing the industry, including facility design, tech transfer and comparability, QRM, product realization, regulation and compliance, and product characterization testing. The Conference will also include a panel discussion on the global perspective regarding regulatory aspects of cell and gene therapy.

Plus, with plenty of networking opportunities, the Conference includes ample time to connect with vendors and suppliers committed to providing the most innovative solutions for the biopharmaceutical industry and to engage with other experts working to advance the field of cell and gene therapy.

If you work in the development, manufacture, or regulation of cell and gene therapies, this Conference is for you!

The 2019 PDA Biopharmaceuticals Week will also include the 2019 PDA Virus Safety Forum, taking place May 8. Learn all you need to know about viral testing, mitigation, and clearance during this one-day forum, which includes a special session with the Advanced Virus Detection Interest Group.

Register by March 22 to save!